CharlesDHowellMD

PubMed

• 2 citations
  Association of Patients' Perception of Quality of Healthcare Received and Colorectal Cancer Screening Uptake: An Analysis of 2 National Surveys in the USA.
  Karan Chawla, Angesom Kibreab, Victor F. Scott, Edward L. Lee, Farshad Aduli, Hassan Brim, Hassan Ashktorab, Charles D. Howell, Adeyinka O. Laiyemo> ;Medical Principles and Practice. 2021 Jan 1
• 2 citations
  Patterns of Hepatitis C-Related Inpatient Mortality in the United States in the Era of Direct-Acting Antivirals.
  Mohammad S. Alzahrani, Mary K. Maneno, Monika N. Daftary, La’Marcus T. Wingate, Earl B. Ettienne, Charles D. Howell> ;Journal of Gastroenterology and Hepatology Research. 2020 Jun 21
• 15 citations
  Rheumatologic Diseases and the Liver.
  Agazi Gebreselassie, Farshad Aduli, Charles D. Howell> ;Clinics in Liver Disease. 2019 May 1
• 21 citations
  Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.
  Ayse L. Mindikoglu, Antone R. Opekun, William E. Mitch, Laurence S. Magder, Robert H. Christenson, Thomas C. Dowling, Matthew R. Weir, Stephen L. Seliger, Charles D. H...> ;Digestive Diseases and Sciences. 2018 Feb 1
• Tree-based Claims Algorithm for Measuring Pretreatment Quality of Care in Medicare Disabled Hepatitis C Patients.
  Viktor V Chirikov, Fadia T Shaya, Ebere Onukwugha, C Daniel Mullins, Susan dosReis, Charles D Howell> ;Medical Care. 2017 Dec 1
• 38 citations
  Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis
  Ayse L. Mindikoglu, Antone R. Opekun, Nagireddy Putluri, Sridevi Devaraj, David Sheikh-Hamad, John M. Vierling, John A. Goss, Abbas Rana, Gagan Sood, Prasun K. Jalal, ...> ;Translational Research. 2018 May 1
• 7 citations
  Using Patients' Social Network to Improve Compliance to Outpatient Screening Colonoscopy Appointments Among Blacks: A Randomized Clinical Trial
  Adeyinka O. Laiyemo, John Kwagyan, Carla Williams, Jessica Rogers, Angesom Kibreab, Momodu Jack, Edward E. Lee, Hassan Brim, Hassan Ashktorab, Charles D. Howell, Duane...> ;The American Journal of Gastroenterology. 2017 Oct 1
• 8 citations
  Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.
  Erikka Loftfield, Thomas R. O'Brien, Ruth M. Pfeiffer, Charles D. Howell, Ron Horst, Ludmila Prokunina-Olsson, Stephanie J. Weinstein, Demetrius Albanes, Timothy R. Mo...> ;Plos One. 2016 Nov 10
• 1 citations
  Research is needed on the difficult‐to‐cure population of hepatitis C virus patients with disability
  Viktor V. Chirikov, Fadia T. Shaya, C.D. Mullins, Susan dosReis, Eberechukwu Onukwugha, Charles D. Howell> ;Hepatology. 2016 Jun 1
• 176 citations
  Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1
  Thomas D. Boyer, Arun J. Sanyal, Florence Wong, R. Todd Frederick, John R. Lake, Jacqueline G. O'Leary, Daniel Ganger, Khurram Jamil, Stephen Chris Pappas, Samuel H. S...> ;Gastroenterology. 2016 Jun 1
• 24 citations
  Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines.
  Ayse L. Mindikoglu, Thomas C. Dowling, Laurence S. Magder, Robert H. Christenson, Matthew R. Weir, Stephen L. Seliger, William R. Hutson, Charles D. Howell> ;Clinical Gastroenterology and Hepatology. 2016 Apr 1
• 51 citations
  Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data
  Julius M. Wilder, Lennox J. Jeffers, Natarajan Ravendhran, Mitchell L. Shiffman, John E. Poulos, Mark S. Sulkowski, Norman Gitlin, Kimberly A. Workowski, Yanni Zhu, Je...> ;Hepatology. 2016 Feb 1
• 1 citations
  Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis C
  Viktor V. Chirikov, Fadia T. Shaya, C. Daniel Mullins, Susan dosReis, Ebere Onukwugha, Charles D. Howell> ;Expert Review of Gastroenterology & Hepatology. 2015 Nov 2
• 55 citations
  Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance
  Thomas R. O'Brien, Ruth M. Pfeiffer, Ashley Paquin, Krystle A. Lang Kuhs, Sabrina Chen, Herbert L. Bonkovsky, Brian R. Edlin, Charles D. Howell, Gregory D. Kirk, Mark ...> ;Journal of Hepatology. 2015 Nov 1
• 10 citations
  Contextual analysis of determinants of late diagnosis of hepatitis C virus infection in medicare patients.
  Viktor V. Chirikov, Fadia T. Shaya, Charles D. Howell> ;Hepatology. 2015 Jul 1
• 59 citations
  Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure
  Norah A. Terrault, Tarek Hassanein, Charles D. Howell, Shobha Joshi, John R. Lake, Linda Sher, Hugo E. Vargas, Joe McIntosh, Shande Tang, Tim M Jenkins> ;Journal of Hepatology. 2014 Dec 1
• Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis C
  Viktor V. Chirikov, Fadia T. Shaya, Charles D. Howell> ;Expert Review of Gastroenterology & Hepatology. 2014 Oct 17
• 105 citations
  Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy
  Don C. Rockey, John M. Vierling, Parvez S. Mantry, Marwan Ghabril, Robert S. Brown, Olga Alexeeva, Igor A. Zupanets, Vladimir Grinevich, Andrey Baranovsky, Larysa Duda...> ;Hepatology. 2014 Mar 1
• 5 citations
  The hepatitis C crisis in the African American Community: findings and recommendations.
  Rahn K. Bailey, Andrew J. Muir, Charles D. Howell, Cedric Bright, Philip R. Roane, Eyasu H. Teshale, Courtney M. Johnson, Sadye B. Curry, Azela C. Collins, Sharon Alli...> ;Journal of the National Medical Association. 2013 Jun 1
• Reply to: "Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling".
  Charles D. Howell, Runyan Jin, Thomas C. Dowling> ;Journal of Hepatology. 2013 Apr 1
• 727 citations
  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
  Ludmila Prokunina-Olsson, Brian Muchmore, Wei Tang, Ruth M. Pfeiffer, Heiyoung Park, Harold Dickensheets, Dianna Hergott, Patricia Porter-Gill, Adam Mumy, Indu Kohaar,...> ;Nature Genetics. 2013 Feb 1
• 14 citations
  Optimum ribavirin exposure overcomes racial disparity in efficacy of peginterferon and ribavirin treatment for hepatitis C genotype 1.
  Runyan Jin, Ling Cai, Ming Tan, John G. McHutchison, Thomas C. Dowling, Charles D. Howell> ;The American Journal of Gastroenterology. 2012 Oct 23
• 16 citations
  Population pharmacokinetics and pharmacodynamics of ribavirin in patients with chronic hepatitis C genotype 1 infection.
  Runyan Jin, Michael J. Fossler, John G. McHutchison, Charles D. Howell, Thomas C. Dowling> ;The AAPS Journal. 2012 May 26
• 8 citations
  End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection.
  Florence Aslinia, Sharmeel K. Wasan, Ayse L. Mindikoglu, Olukemi A Adeyemo, Benjamin Philosophe, Cinthia B. Drachenberg, Charles D. Howell> ;Journal of Viral Hepatitis. 2012 Jan 16
• 23 citations
  Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1.
  Charles D. Howell, Alexis Gorden, Kathleen A. Ryan, Alexander J. Thompson, Chadi Ibrahim, Michael W. Fried, Nezam H. Afdhal, John G. McHutchison, Kevin V. Shianna, Dav...> ;Journal of Hepatology. 2012 Mar 1
• Join now to see all